相关实验视频

Updated: Jun 18, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

在肺移植患者中,产生KPC-2的Pseudomonas aeruginosa高风险序列类型463的进化适应

Piaopiao Zhang¹, Juan Hu², Wenhao Wu¹

¹State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

International journal of antimicrobial agents

|July 28, 2024

概括

这项研究揭示了高风险的Pseudomonas aeruginosa菌株 (ST 463) 在抗生素治疗期间如何适应,发展出高水平的耐药性和免疫逃避. 这些适应机制解释了其在医疗保健环境中的持久性和传播.

科学领域:

微生物学微生物学
基因组学就是基因组学.
进化生物学进化生物学

背景情况:

产生KPC-2的Pseudomonas aeruginosa序列类型 (ST) 463是中国日益严重的公共卫生问题.
这种高风险的克隆构成重大威胁,特别是在临床环境中.

研究的目的:

在抗生素治疗期间,研究KPC-2-产生P. aeruginosa ST 463在宿主内部的适应性进化.
发现推动适应的遗传和表型机制.

主要方法:

基因组,转录组和表型分析是在从肺移植患者的连续隔离物上进行的.
在多次抗生素治疗期间收集了分离物.

主要成果:

早期的隔离结果显示,由于blaKPC-2的过度表达和染色体融合,导致了低水平的Ceftazidime/avibactam (CZA) 耐药性.
晚期分离物体在持续CZA暴露后通过blaKPC-14删除产生了高水平的CZA耐药性.
适应包括增加生物膜的形成,亚带状表型 (通过vfr突变) 和增强的免疫逃避.

结论:

在治疗过程中,P. aeruginosa ST 463表现出了显著的适应能力,能够承受治疗过程中的压力.
这些调整有助于其在医疗环境中的持续和传播.

关键词:

塞夫塔胺/阿维巴克坦进化进化进化进化进化进化进化伪omonas aeruginosa 这种类型的病毒.ST463 我们的世界 bla (KPC-2) 的使用情况.这里是vfrfr的vfrfr.

更多相关视频

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

相关概念视频

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...